ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!BSX Company Profile and Key Details
Boston Scientific Corporation
BSX Stock Price Chart
Stock Price Today
Boston Scientific Corporation (BSX) stock declined over -0.13%, trading at $105.23 on NYSE, down from the previous close of $105.36. The stock opened at $105.46, fluctuating between $104.45 and $105.65 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
Marlborough, MA 01752-1234
United States
Website: https://www.bostonscientific.comContact: 508 683 4000About Company
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Company Information
| Employees | 48000 |
| Beta | 0.81 |
| Sales or Revenue | $14.24B |
| 5Y Sales Change% | 0.378% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
Boston Scientific Corporation (NYSE: BSX) stock price is $105.23 in the last trading session. During the trading session, BSX stock reached the peak price of $105.65 while $104.45 was the lowest point it dropped to. The percentage change in BSX stock occurred in the recent session was -0.13% while the dollar amount for the price change in BSX stock was -$0.14.
The NYSE listed BSX is part of Medical - Devices industry that operates in the broader Healthcare sector. Boston Scientific Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Joseph M. Fitzgerald
Executive Vice President & Group Pres of Cardiology
Mr. John Bradley Sorenson
Executive Vice President of Global Operations
Ms. Mary Beth Moynihan
Senior Vice President of Market Access & Chief Marketing Officer
Mr. Daniel J. Brennan
Executive Vice President & Chief Financial Officer
Ms. Susan Vissers Lisa
Vice President of Investor Relations
Ms. Jodi Euerle Eddy
Senior Vice President and Chief Information & Digital Officer
Mr. Vance R. Brown
Senior Vice President, Gen. Counsel & Corporation Sec.
Mr. Jonathan R Monson
Senior Vice President, Global Controller & Chief Accounting Officer
Ms. Catherine Jennings
Vice President of Global Marketing & New Bus. Devel. of Peripheral Interventions
Mr. Michael F. Mahoney
Chairman, Pres & Chief Executive Officer
Mr. Arthur C. Butcher
Executive Vice President and Group Pres of MedSurg & Asia Pacific
Mr. Arthur Crosswell Butcher
Executive Vice President and Group Pres of MedSurg & Asia Pacific
Mr. Jeffrey B. Mirviss
Executive Vice President & Pres of Peripheral Interventions
BSX's closing price is 60.81% higher than its 52-week low of $65.52 where as its distance from 52-week high of $107.17 is -1.69%.
Number of BSX employees currently stands at 48,000.
Official Website of BSX is: https://www.bostonscientific.com
BSX could be contacted at phone 508 683 4000 and can also be accessed through its website. BSX operates from 300 Boston Scientific Way, Marlborough, MA 01752-1234, United States.
BSX stock volume for the day was 1.63M shares. The average number of BSX shares traded daily for last 3 months was 5.43M.
The market value of BSX currently stands at $155.29B with its latest stock price at $105.23 and 1.48B of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com